(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EB ETTA BIOTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EB ETTA BIOTECH

ST13

US500000097149395

Class

10

Filing

97149395

Registration

7134369

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

08/08/2023

Trademark type

Combined

Nice classes

10

Filing date

11/30/2021

Registration date

08/08/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/08/2023

Last transaction

08/08/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/25/2022

First use in commerce

08/25/2022

Drawing code

3

Owner type

99

Owner location

Suzhou, CN

Examiner

MORRIS, KRISTINA

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized letters "E" and "B" appearing inside a square to the left of the stylized lettering "ETTA BIOTECH".

Holders and representatives

Holders

Etta Biotech Co., Ltd.

Representatives

Paulo A. de Almeida Patel & Almeida PC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical apparatus and instrumentselectroporation device and electrotransfection device for cell modification and drug delivery

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/08/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/07/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/06/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/06/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/03/2023

IUAF

USE AMENDMENT FILED

06/07/2023

EISU

TEAS STATEMENT OF USE RECEIVED

06/07/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/13/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2022

PUBO

PUBLISHED FOR OPPOSITION

10/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/10/2022

DOCK

ASSIGNED TO EXAMINER

09/08/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/04/2021

NWAP

NEW APPLICATION ENTERED

12/03/2021

Continuous trademark protection

Get notified about every new filing that threatens EB ETTA BIOTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.